MISBAH NAZIR: Open Payments
NPI 1487323903 · PENNINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 36 payments from 14 companies in 2025. Trend: 2023 $186 · 2024 $796 · 2025 $1,078
Food & beverage: $902Education: $175
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 10 | $474 |
| Regeneron Healthcare Solutions, Inc. | 3 | $120 |
| ABBVIE INC. | 5 | $93 |
| Janssen Biotech, Inc. | 1 | $90 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $48 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $40 |
| LEO Pharma Inc. | 2 | $38 |
| Galderma Laboratories, L.P. | 2 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
Products named: OPZELURA, DUPIXENT, TREMFYA, SKYRIZI, Cabtreo, ADBRY, NEMLUVIO, EBGLYSS.
Industry payments across NJ — which companies pay providers there.
